ClinicalTrials.gg
Not yet recruitingNCT07857590APPETE INTAKEUpdated Oct 5, 2026

APPETE INTAKE: A Study on the Effects of Adding an Appetite Engine to a Nutritional Drink

An interventional study of Test nutritional drink and Control nutritional drink in Appetite Regulation, sponsored by Nutricia Research. Not yet recruiting at 1 site in Poland. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-10-05.

Sponsored by Nutricia Research (part of Danone) · Not applicable, Interventional, and Basic science

How we know

Updated Oct 5, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
68
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

The aim of this study is to investigate the effect of adding an appetite engine to a high-protein oral nutritional supplement (ONS) on acute dietary intake in older adults.

02

Conditions studied

  • Appetite Regulation
03

In context

Lead sponsor

Nutricia Research is the lead sponsor of 51 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Adults aged 65 years or older Older adults in need of additional nutritional support, such as those currently using oral nutritional supplements or identified as malnourished or at risk of malnutrition Able to consume oral nutritional drinks as part of daily nutrition Able and willing to provide written

Exclusion criteria

Exclusion Criteria:

Medical conditions that significantly affect food intake, digestion, or gastrointestinal function Conditions or treatments known to markedly influence appetite or nutritional intake Known allergies or intolerances to components of the nutritional drinks Use of tube feeding or parenteral nutrition Participation in another interventional study during the study period Any condition that, in the investigator's opinion, could interfere with study participation or compliance

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
68 participants (estimated)

Study arms

  • Experimental
    Test ONS with appetite engine

    ONS containing appetite engine

    Dietary Supplement: Test nutritional drink

  • Active comparator
    Control ONS

    ONS without appetite engine

    Dietary Supplement: Control nutritional drink

Interventions

  • Dietary supplementTest nutritional drink

    Nutritional drink consumed twice daily

  • Dietary supplementControl nutritional drink

    Oral nutritional drink consumed twice daily

06

What researchers measure

Primary outcomes

  1. Acute dietary intake

    Amount of energy consumed during a single meal after intake of a nutritional drink.

    Time frame: Assessed on Day 1 of each intervention period.

Secondary outcomes

  1. Satiety and appetite responses

    Participant-reported feelings related to hunger and fullness assessed using standardized questionnaires.

    Time frame: From before intake up to 120 minutes after intake of the nutritional drink on Day 1 of each intervention period.

  2. Product adherence

    Compliance with consumption of the assigned nutritional drink.

    Time frame: Assessed daily during each intervention period (up to 7 days).

07

Study locations

1 site
  • Novamedpharm
    Krakow, Poland
    • Dr. Nowak · Contact
    • Dr. Nowak · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2026; primary completion for Sep 2027, 12 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 18, 2026
First posted
Oct 5, 2026
StartEst.
Sep 15, 2026
Primary completionEst.
Sep 30, 2027
CompletionEst.
Dec 31, 2027
Last update
Oct 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 5, 2026
Show all 1 update
  1. Oct 5, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07857590
Lead sponsor
Nutricia Research
Responsible party
Sponsor
First posted
Oct 5, 2026
Start date
Sep 15, 2026 (estimated)
Primary completion
Sep 30, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Oct 5, 2026

Study contacts

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion